Replies to post #118619 on Biotech Values

[DewDiligence]

I’m not impressed with RNN, but I haven’t looked at it closely in a while.

The CEO just bought shares

Not true—here’s the footnote from the SEC filing:

http://sec.gov/Archives/edgar/data/1228627/000114036111020856/xslF345X03/doc1.xml

On April 1, 2011, the reporting person acquired 320,846 shares from a family trust in satisfaction of an existing indebtedness of that trust to the reporting person in the amount of $391,423.

In other words, this was an asset transfer, not an open-market purchase.